1899 related articles for article (PubMed ID: 16506274)
21. Endothelial dysfunction in obesity: etiological role in atherosclerosis.
Meyers MR; Gokce N
Curr Opin Endocrinol Diabetes Obes; 2007 Oct; 14(5):365-9. PubMed ID: 17940464
[TBL] [Abstract][Full Text] [Related]
22. Endothelial function, insulin action and cardiovascular risk factors in young healthy adult offspring of parents with Type 2 diabetes: effect of vitamin E in a randomized double-blind, controlled clinical trial.
McSorley PT; Bell PM; Young IS; Atkinson AB; Sheridan B; Fee JP; McCance DR
Diabet Med; 2005 Jun; 22(6):703-10. PubMed ID: 15910620
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.
Rask-Madsen C; King GL
Nat Clin Pract Endocrinol Metab; 2007 Jan; 3(1):46-56. PubMed ID: 17179929
[TBL] [Abstract][Full Text] [Related]
24. [Rheumatoid arthritis, inflammation, and atherosclerosis].
Hürlimann D; Enseleit F; Ruschitzka F
Herz; 2004 Dec; 29(8):760-8. PubMed ID: 15599672
[TBL] [Abstract][Full Text] [Related]
25. [Insulin resistance and vascular function].
Naruse M; Tanabe A; Takagi S; Tago K; Takano K
Nihon Rinsho; 2000 Feb; 58(2):344-7. PubMed ID: 10707556
[TBL] [Abstract][Full Text] [Related]
26. Coronary endothelial vasodilator dysfunction: clinical relevance and therapeutic implications.
Zeiher AM; Schächinger V
Z Kardiol; 1994; 83 Suppl 4():7-14. PubMed ID: 7856284
[TBL] [Abstract][Full Text] [Related]
27. Endothelial dysfunction in metabolic syndrome: prevalence, pathogenesis and management.
Tziomalos K; Athyros VG; Karagiannis A; Mikhailidis DP
Nutr Metab Cardiovasc Dis; 2010 Feb; 20(2):140-6. PubMed ID: 19833491
[TBL] [Abstract][Full Text] [Related]
28. [The role of endothelial dysfunction in the pathogenesis and in clinical practice of atherosclerosis. Current evidences].
Patti G; Melfi R; Di Sciascio G
Recenti Prog Med; 2005 Oct; 96(10):499-507. PubMed ID: 16491775
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide and vascular insulin resistance.
Wu G; Meininger CJ
Biofactors; 2009; 35(1):21-7. PubMed ID: 19319842
[TBL] [Abstract][Full Text] [Related]
30. Endothelium dysfunction in the coronary circulation.
Lüscher TF; Noll G
J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S16-26. PubMed ID: 7700060
[TBL] [Abstract][Full Text] [Related]
31. The ageing endothelium, cardiovascular risk and disease in man.
Versari D; Daghini E; Virdis A; Ghiadoni L; Taddei S
Exp Physiol; 2009 Mar; 94(3):317-21. PubMed ID: 18805864
[TBL] [Abstract][Full Text] [Related]
32. The metabolic syndrome: metabolic changes with vascular consequences.
Wassink AM; Olijhoek JK; Visseren FL
Eur J Clin Invest; 2007 Jan; 37(1):8-17. PubMed ID: 17181562
[TBL] [Abstract][Full Text] [Related]
33. Is insulin resistance atherogenic? A review of the evidence.
Ferrannini E; Iozzo P
Atheroscler Suppl; 2006 Aug; 7(4):5-10. PubMed ID: 16824807
[TBL] [Abstract][Full Text] [Related]
34. Family history of diabetes is a major determinant of endothelial function.
Goldfine AB; Beckman JA; Betensky RA; Devlin H; Hurley S; Varo N; Schonbeck U; Patti ME; Creager MA
J Am Coll Cardiol; 2006 Jun; 47(12):2456-61. PubMed ID: 16781373
[TBL] [Abstract][Full Text] [Related]
35. Why does diabetes mellitus increase the risk of cardiovascular disease?
Shahab A
Acta Med Indones; 2006; 38(1):33-41. PubMed ID: 16479030
[TBL] [Abstract][Full Text] [Related]
36. Endothelial dysfunction in type 2 diabetes: effect of antioxidants.
Sena CM; Nunes E; Louro T; Proença T; Seiça RM
Rev Port Cardiol; 2007 Jun; 26(6):609-19. PubMed ID: 17849945
[TBL] [Abstract][Full Text] [Related]
37. Calcium channel blockers, endothelial dysfunction, and combination therapy.
Schulman IH; Zachariah M; Raij L
Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):40-5. PubMed ID: 16640172
[TBL] [Abstract][Full Text] [Related]
38. Insulin resistance, metabolic syndrome and endothelial dysfunction.
Bigazzi R; Bianchi S
J Nephrol; 2007; 20(1):10-4. PubMed ID: 17347967
[TBL] [Abstract][Full Text] [Related]
39. Vascular wall function as a risk marker for cardiovascular disease.
Cohn JN
J Hypertens Suppl; 1999 Dec; 17(5):S41-4. PubMed ID: 10706325
[TBL] [Abstract][Full Text] [Related]
40. Insulin resistance, metabolic syndrome and vascular diseases: update on mechanistic linkages.
Lteif A; Mather K
Can J Cardiol; 2004 Aug; 20 Suppl B():66B-76B. PubMed ID: 15309208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
